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Abstract
Background: Worldwide, bacterial vaginosis (BV) is the most common vaginal disorder. It is associated with risk for 
preterm birth and HIV infection. The etiology of the condition has been debated for nearly half a century and the lack 
of knowledge about its cause and progression has stymied efforts to improve therapy and prevention. Gardnerella 
vaginalis was originally identified as the causative agent, but subsequent findings that it is commonly isolated from 
seemingly healthy women cast doubt on this claim. Recent studies shedding light on the virulence properties of G. 
vaginalis, however, have drawn the species back into the spotlight.
Results: In this study, we sequenced the genomes of a strain of G. vaginalis from a healthy woman, and one from a 
woman with bacterial vaginosis. Comparative analysis of the genomes revealed significant divergence and in vitro 
studies indicated disparities in the virulence potential of the two strains. The commensal isolate exhibited reduced 
cytotoxicity and yet the cytolysin proteins encoded by the two strains were nearly identical, differing at a single amino 
acid, and were transcribed at similar levels. The BV-associated strain encoded a different variant of a biofilm associated 
protein gene and demonstrated greater adherence, aggregation, and biofilm formation. Using filters with different 
pore sizes, we found that direct contact between the bacteria and epithelial cells is required for cytotoxicity.
Conclusions: The results indicated that contact is required for cytotoxicity and suggested that reduced cytotoxicity in 
the commensal isolate could be due to impaired adherence. This study outlines two distinct genotypic variants of G. 
vaginalis, one apparently commensal and one pathogenic, and presents evidence for disparate virulence potentials.
Background
G. vaginalis has had a checkered taxonomic beginning. It
was originally isolated by Leopold [1] and later associated
with the vaginal disorder now referred to as bacterial vag-
inosis and named Haemophilus vaginalis by Gardner and
Dukes [2,3]. Subsequently, metabolic requirements and
gram staining led to its reclassification within the genus
Corynebacterium. Greenwood and Pickett suggested that
the organism did not belong in this genus either and that
it be placed in its own genus, named after its discoverer
[4]; a contention later supported by DNA-DNA hybrid-
ization [5]. Gardnerella  is in the Family Bifidobacteri-
aceae and is most closely related to species in the Genus
Bifidobacterium. The cells are small, nonmotile pleomor-
phic rods, which may be piliated. The length of the rods
and gram staining vary depending on the growth medium
[6]. Electron microscopy and the lack of lipopolysaccha-
ride production demonstrates that the cell wall is gram-
positive, although the peptidoglycan layer can be thinner
than many gram-positive organisms, resulting in negative
gram staining [7]. G. vaginalis is a fastidious organism
and requires complex medium for growth. Studies using
metabolic methods of identification indicate that it is cat-
alase-negative, exhibits α-glucosidase activity, starch
hydrolysis, hippurate hydrolysis, acid phosphatase activ-
ity, but lacks gelatin and esculin hydrolysis, and salt toler-
ance [6]. G. vaginalis is anaerobic and can utilize the
carbohydrates dextrin, fructose, glucose, maltose, ribose,
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starch, and sucrose through fermentation. Some strains
ferment mannose, galactose, and sucrose, and a few
strains ferment xylose and trehalose but it does not fer-
ment mannitol, raffinose, rhamnose, or sorbitol [6].
Despite the fact that bacterial vaginosis (BV) is the
leading vaginal disorder globally, very little is known
about its etiology or pathogenesis. It fails to conform to
any of Koch's postulates; it is not associated with a single
bacterial species, no single species has ever been found to
reliably elicit the disorder in healthy women, and the
adaptation of the bacterial species involved to life in the
human host has precluded the development of a useful
animal model. Gardner and Dukes identified G. vaginalis
as the etiologic agent but findings that pure cultures did
not always cause BV drew this allegation into question
[3,8]. Subsequent studies analyzed the role of additional
species such as Atopobium vaginae and  Mycoplasma
hominis, but efforts have yet to unequivocally establish
the role of a single species [9,10]. Recent studies of the
virulence properties of G. vaginalis have revealed its abil-
ity to adhere avidly to and establish a tenacious biofilm on
the vaginal epithelium in women with BV and have char-
acterized the molecular basis for its cytotoxicity [11,12].
These virulence studies along with findings that G. vagi-
nalis is the only species that can be detected in the vast
majority of cases of BV and increasing reports of extrav-
aginal infections in which it is the only species isolated,
s u c h  as  ba ct e r e m ia  a n d  os t eo m y e l i t is,  h a v e  d r a wn  t h i s
species back into the spotlight and resurrected the notion
of its pathogenic potential [13-16].
The role of G. vaginalis in BV has also been disputed
because the organism can inhabit the genital tract of
healthy women [17,18]. However, the numbers of G. vagi-
nalis on the vaginal epithelium of healthy women are sev-
eral logs lower than the numbers found in women with
BV [11,18,19]. In addition, it has been reported recently
that the biotypes of G. vaginalis isolated from healthy
women differ from those isolated from women with BV
[20]. The lack of genetic characterization of this organism
leaves open the possibility that distinct pathogenic and
non-pathogenic strains or even subspecies exist. The
Human Microbiome Project, an effort supported by the
NIH, will soon produce a tremendous amount of genetic
information about the bacteria associated with BV and
efforts are underway to sequence strains of G. vaginalis,
A. vaginae, and Mobiluncus. In an effort to better under-
stand the physiology and pathogenic potential of G. vagi-
nalis, we performed whole genome sequence analysis of
an isolate from a case of BV (G. vaginalis strain AMD),
and to determine whether isolates may vary in their
pathogenic potential, we also performed whole genome
sequence analysis of an isolate from a healthy woman (G.
vaginalis strain 5-1). We analyzed the virulence potential
of these two strains using a series of in vitro assays to
quantify their cytotoxic activities, their ability to adhere
to cervical epithelial cells, and their capacity for biofilm
formation.
Results
Whole genome sequence analysis
Pyrosequencing yielded high coverages of the BV-associ-
ated  G. vaginalis strain, 5-1 (accession number:
ADAM00000000) and the healthy subject isolate, AMD
(accession number: ADAN00000000) genomes (~175X
and ~130X, respectively). The data for both genomes
assembled into approximately 20 contigs greater than 500
bp. Both genomes were estimated at approximately 1.65
Mb. In a MUMmer alignment of the genomic sequences,
the minimum percent identity between the two strains
was 76.66% and the maximum was 99.07%, with an over-
all average of 93.62%. GBrowse sites were designed for
strains 5-1 and AMD http://www.gardnere-
lla.mic.vcu.edu. Overall GC content figures were 41.95%
(5-1) and 42.08% (AMD), and the numbers of protein
coding genes predicted were 1,340 (5-1) and 1,318
(AMD). There was only one complete assembled copy of
the ribosomal RNA gene cluster, suggesting that all cop-
ies are identical or close to it. Examination of contig
boundaries suggests that there are at least two and proba-
bly three or four copies of the rRNA gene cluster . The
number of predicted tRNAs was identical in the two
strains: 45.
Metabolic pathways in the two strains
Analysis of the metabolic potential yielded interesting
insights into the basis for the complex growth require-
ments of this fastidious organism [21]. Metabolic path-
ways for amino acid synthesis are absent, apart from a
few possible short conversions including fumarate to L-
aspartate. Pathways for O-glycan, N-glycan, peptidogly-
can, and lipopolysaccharide biosynthesis seemed to be
well populated with the required enzymes. In addition,
many of the required enzymes that convert L-amino acids
to D-amino acids were identified. The portions of the
pentose phosphate pathway allowing synthesis of the
required precursors of nucleotide biosynthesis were also
present. Purine and pyrimidine biosynthesis pathways
were represented by a number of enzymes, permitting
synthesis of several (but not all) bases and nucleotides.
Interestingly, both strains appear to lack two enzymes
that are essential for glycolysis; phosphofructokinase, and
fructose-bisphosphate aldolase. If the enzymes are truly
absent, this deficiency could be partially compensated by
the pentose phosphate pathway. Another possibility is
that  G. vaginalis performs these functions using novel
enzymes that were not identified in our similarity
searches.Harwich et al. BMC Genomics 2010, 11:375
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Putative virulence factors in both strains
The only characterized virulence factor in G. vaginalis is
vaginolysin [12]. Vaginolysin is a cholesterol-dependent
cytolysin that may contribute to virulence by making cel-
lular contents more available as a substrate for bacterial
growth. This cytolytic action may also have the coinci-
dental effect of making the vaginal epithelium more per-
meable to HIV virions. The gene for vaginolysin, vly, in
strain 5-1 exhibited 89% identity at the nucleotide level
and 94% identity at the amino acid level to vly from G.
vaginalis strains 14019, 14018, and 49145 [12]. Vly from
strains 5-1 and AMD were 99% identical at the amino
acid level, differing at a single amino acid (T35A).
Analysis of the G. vaginalis genome revealed a number
of additional putative virulence factors, including a gene
with similarity to the P30/P32 adhesins (GV51_0007,
GVAMD_0260). These adhesins are produced by species
of Mycoplasma and are involved in adherence to human
tissues [22]. Previous reports have demonstrated that
fresh clinical isolates of G. vaginalis are piliated, but sug-
gest that pilus production may be lost upon in vitro pas-
sage of the bacteria [23,24]. However, even though loci
likely to be involved in pilus assembly were present
(GV51_0383 - 0387, GVAMD_1118 - 1122), we were
unable to identify pili by transmission electron micros-
copy of strains 5-1 and AMD, even when the bacteria
when in vitro culture was restricted (Fig. 1).
Proteins encoded in only one strain
OrthoMCL analysis was performed to identify proteins
putatively present in only one strain (Table 1). A number
of these were small, hypothetical proteins that could rep-
resent pseudogenes and several did not exhibit significant
similarity to any proteins of known function. Strain 5-1
contained a number of putative phage proteins that were
absent in AMD. Strain AMD contained a number of
putative serine-threonine kinases not present in 5-1,
however the role of these kinases was unclear from simi-
larity searches. AMD also contained an apparent toxin-
antitoxin gene cassette. Interestingly, the antitoxin pro-
tein exhibited 100% identity to a protein from A. vaginae
and 65% identity to a protein from M. mulieris suggesting
that horizontal gene transfer occurs between BV-associ-
ated bacterial species.
Putative antibiotic resistance determinants
BV can be difficult to treat and the rate of relapse or
recurrence is 50% within a year [25]. Resistance to met-
ronidazole, the drug of choice for BV therapy, has been
seen in some strains of G. vaginalis, as has resistance to
tetracycline [26]. We tested strains 5-1 and AMD for in
vitro susceptibilities to 13 different antibiotics (Table 2).
Both strains were sensitive to tetracycline (MIC = 0.5 μg/
mL) and appeared to lack the tetM gene, found in tetracy-
cline-resistant strains of G. vaginalis [27].
Therapeutically achievable levels of metronidazole are
generally effective against bacteria with an MIC < = 8 μg/
mL, whereas those with an MIC = 16 μg/mL are consid-
ered intermediate resistant and bacteria with an MIC > =
32 μg/mL are considered resistant [28]. Clinical cure rates
of 75% have been reported for oral metronidazole therapy
[29]. Both strains exhibited intermediate resistance with
MICs of 19.5 μg metronidazole/ml. The most well-char-
acterized mechanism of resistance to metronidazole is
inactivation or deletion of genes with nitroreductase
activity [30]. Both strains had nitroreductase genes
(GV51_0575, GV51_0595, GVAMD_0064, and
GVAMD_0125) but the expression of the genes and func-
tionality of the proteins was not determined in this study.
Nalidixic acid resistance in G. vaginalis has been well
established and strains 5-1 and AMD both exhibited
resistance with an MIC above 300 μg/ml. The ORFs
GV51_0431 and GVAMD_1169, which are 98% identical,
are predicted to encode a protein with similarity to multi-
drug efflux pumps in the MATE (multidrug and toxin
exclusion) family. Members of this family include Staphy-
lococcus aureus MepA, which has been shown to confer
fluoroquinolone resistance so this may be involved in
resistance to nalidixic acid (18).
The strains also exhibited intermediate resistance to
kanamycin. Both genomes contained a gene for a phos-
photransferase enzyme family (GV51_0090,
GVAMD_0184; 95% identical). This family includes pro-
teins that inactivate certain aminoglycosides such as
kanamycin. Therefore it is possible that the product of
this gene plays a role in permitting kanamycin resistance
in G. vaginalis.
The genomes also encoded an EmrB/QacA family pro-
tein (GV51_1060, GVAMD_0885; 99% identical), which
could confer resistance to certain streptogramins, how-
ever, the strains were both susceptible to clindamycin and
erythromycin, although strain 5-1 was more sensitive to
erythromycin than was strain AMD.
Figure 1 Pili were not detectable on strains AMD and 5-1. Tandem 
Electron Microsopy was used to investigate pilus expression by the 
two strains. The cell surfaces are shown at high resolution and suggest 
the absence of pilus production under the conditions used in this 
study.Harwich et al. BMC Genomics 2010, 11:375
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Table 1: ORFs unique to one or the other G. vaginalis strains.
Unique to 
strain
Gene Identifier Predicted function/homologues Unique to 
strain
Gene Identifier Predicted function/
homologues
AMD Gv1_0004 GVAMD_0044 No significant similarity 5-1 Gv1_0006 GV51_0275 Hypothetical protein
Gv1_0004 GVAMD_0852 No significant similarity Gv1_0006 GV51_0972 Hypothetical protein
Gv1_0004 GVAMD_1243 Hypothetical protein Gv1_0006 GV51_1019 Hypothetical protein
Gv1_0004 GVAMD_0114 No significant similarity Gv1_0008 GV51_0361 Site specific recombinase
Gv1_0005 GVAMD_0177 Serine/threonine protein kinase Gv1_0008 GV51_1208 Phage-like integrase
Gv1_0005 GVAMD_1234 Serine/threonine protein kinase Gv1_0009 GV51_0427 Conserved hypothetical 
protein
Gv1_0005 GVAMD_1232 Serine/threonince protein 
kinase
Gv1_0009 GV51_1210 Conserved hypothetical 
protein
Gv1_0005 GVAMD_0389 Serine/threonince protein 
kinase
Gv1_0010 GV51_0968 Phage associated protein
Gv1_0011 GVAMD_0742 ABC transporter Gv1_0010 GV51_0974 Conserved hypothetical 
protein
Gv1_0011 GVAMD_0743 ABC transporter Gv1_0012 GV51_0058 Type 1 restriction 
modification system
Gv1_0016 GVAMD_0086 No significant similarity Gv1_0012 GV51_0345 Type 1 restriction 
modification system
Gv1_0016 GVAMD_0521 No significant similarity Gv1_0013 GV51_0141 Conserved hypothetical 
protein
Gv1_0017 GVAMD_0113 Hypothetical protein Gv1_0013 GV51_0412 Cell wall hydrolase
Gv1_0017 GVAMD_0456 Hypothetical protein Gv1_0014 GV51_0363 Cell wall protein
Gv1_0018 GVAMD_0143 Conserved hypothetical, 
putative anti-toxin cassette
Gv1_0014 GV51_1225 Hypothetical protein
Gv1_0018 GVAMD_0681 Conserved hypothetical Gv1_0015 GV51_1339 Conserved hypothetical 
protein
Gv1_0019 GVAMD_0390 2-component regulator Gv1_0015 GV51_1340 Conserved hypothetical 
protein
Gv1_0019 GVAMD_0535 Hypothetical, beta-lactamase 
class AHarwich et al. BMC Genomics 2010, 11:375
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Analysis of surface structures
Because we had noted a difference in the level of aggrega-
tion and biofilm formation of the two strains when they
were cultured in 10% human serum (sBHIs), we analyzed
the surface of the bacteria by transmission electron
microscopy. We observed a layer that resembled a poly-
saccharide capsule on the surface of strain 5-1 that was
absent on AMD (Fig. 2).
Cytotoxicity
Despite the finding that the vly genes of AMD and 5-1
encode nearly identical proteins, with only a single amino
acid mismatch, cytotoxicity assays indicated that after 1
hour AMD, the BV-isolate, induced rounding and other
cytopathologic changes in a monolayer of ME-180 cervi-
cal epithelial cells (data not shown), and complete lysis of
the monolayer by 3 hours (Fig. 3B). In contrast, ME-180
cells exposed to the non-BV isolate, 5-1, were still
attached and exhibited normal spreading epithelial mor-
phology after 1 hour (data not shown) and had only
begun to exhibit rounding and other cytopathogenic
changes by 3 hours (Fig. 3C). Strain 5-1 led to complete
disruption of the ME-180 monolayer after 12 hours (data
Gv1_0020 GVAMD_0448 Hypothetical protein
Gv1_0020 GVAMD_0928 Conserved hypothetical protein
Gv1_0021 GVAMD_0931 Hypothetical protein
Gv1_0021 GVAMD_1004 Hypothetical protein
Table 1: ORFs unique to one or the other G. vaginalis strains. (Continued)
Table 2: In vitro susceptibilities of G. vaginalis strains to 12 antimicobial agents.
Antibiotic MIC (μg/mL)
Strain 5-1 Strain AMD
Ampicillin 0.125 0.125
Nafcillin 0.12 0.12
Ciprofloxacin 1 2
Nalidixic acid 390 390
Chloramphenicol 0.5 1
Minocycline 0.156 0.078
Tetracycline 0.5 0.5
Erythromycin 0.032 0.128
Clindamycin 0.625 0.625
Kanamycin 32 32
Rifampin 0.063 0.063
Metronidazole 19.5 19.5Harwich et al. BMC Genomics 2010, 11:375
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not shown) suggesting that Vly from this strain was func-
tional. To determine if differences in expression of vly
could account for the reduced cytotoxicity associated
with the commensal strain, we compared the vly  pro-
moter regions of the two strains and found that 5-1 was
lacking 2 bp that were present in the AMD vly promoter.
However, quantitative realtime RT-PCR indicated that
transcriptional expression of the vly gene was equivalent
in the two strains (data not shown).
Adherence to epithelial cells
We analyzed the ability of the two G. vaginalis strains to
adhere to cultured ME-180 cervical epithelial cells was
assayed by confocal microscopy. While equal amounts of
the two strains were added to ME-180 monolayers,
adherence of strain AMD was much more pronounced
relative to that of the non-BV isolated strain 5-1 (Fig. 4). It
was also observed that strain AMD was more aggregative
than was strain 5-1. This suggests that the capability of
BV isolates to bind to and adhere to vaginal epithelium
may be higher than non-BV isolates. As pilus expression
could not be demonstrated in either strain, we searched
for other putative adhesins. Both strains harbored a bio-
film associated protein (BAP) family gene (Fig. 5A). BAP
homologues in other species are involved not only in bio-
film formation, but in adherence to epithelial cells as well,
so we compared the sequences of the BAP genes encoded
by 5-1 and AMD. ClustalW alignment of the amino acid
sequences of the BAP family protein encoded by AMD
and 5-1 showed considerable sequence differences
between the two proteins (Fig. 5B). The BAP homologues
had a highly repetitive structure as is characteristic of the
other BAP family proteins (Fig. 5A) and a majority of the
sequence differences between the two strains were
located within the region containing the B, C, and D
repeats. BAP is also predicted to contain several Rib
domains. Rib domains were named after the Rib protein
of Group B Streptococcus, an immunogenic surface pro-
teins with a highly repetitive structure [31]. The number
and distribution of Rib domains in the BAP homologues
differed between AMD and 5-1.
Role of adherence in cytotoxicity
Other cholesterol-dependent cytolysins depend upon
adherence to exert their activity [32]. Because we
observed that AMD exhibited increased adherence, we
investigated the possibility that this was related to the
greater cytotoxic activity associated with AMD. G. vagi-
Figure 4 Adherence of G. vaginalis to cultured vaginal epitheli-
um. Equal amounts of the indicated strains of G. vaginalis (green) were 
added to ME-180 cells (red). The cells were stained with BacLight green 
and Vybrant Red stains respectively. Adherence was analyzed by con-
focal microscopy following incubation and extensive washing with 1X 
PBS.
Figure 2 Transmission Electron Microscopy of G. vaginalis strains. 
The left panel is 5-1 while the panel on the right is AMD. When the 
strains were grown in the presence of 10% human serum, a capsule-
like material was present on 5-1, but was undetectable on AMD.
Figure 3 Cytotoxicity caused by G. vaginalis strains. Equal num-
bers of either AMD, 5-1, or PBS control were either added to a ME-180 
monolayer directly (A-C), or were loaded into transwell filters with ei-
ther 3 μm (D-F) or 0.4 μm (G-I) pore-size. The cells were monitored mi-
croscopically during the incubation for phenotypic alterations 
associated with toxic effects. After incubating the ME-180 cells with 
the bacteria for 3 hours, strain AMD had caused complete lysis of the 
monolayer whereas the cells incubated with strain 5-1 had just begun 
to exhibit rounding. The cytotoxic effects were completely blocked by 
the transwell with 0.4 μm pore size, which did not allow contact be-
tween the ME-180 s and the bacteria while the 3 μm pores, which did 
allow contact, permitted the cytotoxic effects.Harwich et al. BMC Genomics 2010, 11:375
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nalis was added to transwell filters with a pore-size equal
to either 3 μm, to allow the bacteria to penetrate the filter
and make contact with the monolayer, or 0.4 μm, to pre-
vent direct contact of the bacteria and monolayer but to
allow proteins to flow through to the ME-180 s. We found
that direct contact with the monolayer was required for
cytotoxic activity (Fig. 3D-I), suggesting that the disparity
in the adherence of the two strains could account for dif-
ferences in cytotoxic activity.
Capacities for biofilm-formation
The ability to form a biofilm is a marker of potential viru-
lence and a cause of recurrent infections. Since BAP pro-
teins are known to play a role not only in adherence but in
biofilm formation in other species [33], we chose to
investigate whether the disparity in the sequences and
expression of the BAP homologues could translate into
differences in biofilm forming activity. Safranin staining
of biofilms (Fig. 6A) produced by G. vaginalis strains
AMD and 5-1 after 24 hours of growth showed that the
BV-isolate AMD produced a thicker biofilm. Quantitative
measurement of biofilm growth as percentage of total
growth indicated that AMD had a significantly greater
biofilm-forming capacity than the non-BV isolate 5-1
(Fig. 6B). The relationship between biofilm capacity and
association with BV was further investigated using addi-
tional strains. We found that two other G. vaginalis BV-
isolates, strains 101 and 551 produced similar levels of
biofilm growth as did strain AMD and significantly more
than strain 5-1. A second healthy isolate, strain 465,
showed significantly less biofilm growth than the BV-iso-
lates (Fig. 6B). These data suggest that BV-isolates tend to
produce more biofilm growth than do non-BV associated
isolates of G. vaginalis, which would reasonably be con-
sistent with greater virulence.
Discussion
G. vaginalis can be isolated from the majority of BV cases
but it can also be isolated, albeit at much lower numbers,
from healthy women. Very little is currently known about
the genetic composition of G. vaginalis, the diversity of
strains or about its physiology. It has been reported that
Figure 6 Biofilm-forming capacity of G. vaginalis isolates. A) Bio-
films were stained with safranin for a visual assessment of biofilm thick-
ness. B) Because the BV-associated isolate AMD exhibited significantly 
greater biofilm-forming capacity than the non-BV isolate 5-1 we tested 
an additional non-BV isolate (465) and two additional BV isolates (101 
and 551). The percent growth as a biofilm was calculated as OD595 bio-
film/(OD595 biofilm + OD595 planktonic) and is represented graphically. 
The error bars represent standard deviation of 8 independent data 
points.
Figure 5 BAP domain structure and inter-strain conservation. A) Diagram representing the repeat structures found within the BAP encoded by 
G. vaginalis strain 5-1. Repeats units are diagramed above and named based upon the similarity to Bap proteins from other species. B) A ClustalW align-
ment of BAPs from strains AMD and 5-1 is shown, black represents 100% conservation. Rib domains are indicated by red boxes.Harwich et al. BMC Genomics 2010, 11:375
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certain biotypes of G. vaginalis are more frequently asso-
ciated with BV [20]. In order to investigate the possibility
that certain strains are more likely to be associated with
BV, we sequenced a BV-associated strain and a healthy
isolate and characterized their virulence potentials with a
series of in vitro assays for cytotoxicity, adherence, and
biofilm formation. We found that the BV-associated
strain was significantly more cytotoxic than the non-BV
isolate suggesting that differing levels of cytotoxicity may
be related to the propensity of a strain to cause disease.
Proteins encoded by the vly genes differed by only a single
amino acid and the promoters differed by only 2 bp. The
disparity in the level of cytotoxicity of the two strains
could be related to the amino acid substitution, but the
residue is not near the active site or other amino acids
known to play a key role in function [12]. The differences
i n  c y t o t o x i c i t y  a r e  l i k e l y  a  f u n c t i o n  o f  a d h e r e n c e .  W e
found that strain AMD adheres more avidly to cultured
vaginal epithelial cells than does the non-BV isolate, 5-1.
Therefore it is possible that the increase in cytotoxicity
seen with strain AMD is simply due to its ability to
adhere and thereby deliver vaginolysin more directly to
the eukaryotic monolayer. Consistent with this hypothe-
sis was the finding that a 0.4 μM filter effectively blocked
G. vaginalis-mediated cytotoxicity. If the toxic effector
molecule produced by the bacteria was freely secreted in
sufficient concentrations and the secreted form was cyto-
toxic, then phenotypic changes of the ME-180 monlayer
would have been seen even under conditions that pre-
vented direct cell to ce ll contact, i.e. the 0.4 μM filter .
However the filter ablated cytotoxicity in ME-180 s sug-
gesting that direct contact between G. vaginalis and the
vaginal epithelium is required for effective delivery of the
vly gene product, as is the case with other cholesterol-
dependent cytolysins [32].
These results have also demonstrated a clear difference
in the ability of various strains to adhere to cultured cer-
vical epithelial cells. While both AMD and 5-1 were able
to adhere to the ME-180 monolayer, AMD exhibited
heightened adherence. Adherence is a prerequisite for
infection, and these results suggest that BV isolates are
able to adhere, and thus establish an infection much more
readily than non-BV isolates. Factors influencing the abil-
ity of a given strain to adhere to eukaryotic cells would be
governed by the proteins and structures present upon the
bacterial cell surface and the interaction between those
factors and the ME-180 surface proteins and structures.
We found a gene encoding a biofilm associated protein
(BAP) family protein. BAP proteins are large, cell wall-
anchored adhesins that can mediate both adherence to
host cells and intercellular adherence, which contributes
to biofilm formation [33,34]. Interestingly, the gene
sequences for AMD and 5-1 BAP were quite disparate.
This was particularly noticeable in the repeat regions, the
region of BAP proteins that generally mediates adher-
ence. We also noted that the healthy isolate appeared to
be coated in a capsular structure, whereas the BV-associ-
ated isolated did not appear to express this structure.
This may negatively impact adherence to vaginal epithe-
lial cells, or biofilm formation. Pneumococci produce a
capsule that has been linked to a decrease in biofilm for-
mation supporting this hypothesis [35]. Both genomes
contained multiple potential operons for capsular poly-
saccharide biosynthesis although there was significant
divergence in the proteins encoded by the two strains.
We also found a significant difference in the propensity
of the two strains to form a biofilm in vitro. Biofilm for-
mation by G. vaginalis has recently been implicated in BV
[11]. The ability for a strain to grow as a biofilm would
likely confer resistance to mucosal immune defenses and
antibiotic resistance, which could contribute to initial and
recurrent colonization. Furthermore, lactobacilli nor-
mally associated with the healthy vagina produce byprod-
ucts such as lactic acid and hydrogen peroxide that
normally suppress the growth of anaerobes such as G.
vaginalis, but biofilm formation leads to increased resis-
tance to these byproducts [36]. Therefore, biofilm forma-
tion may enable proliferation of G. vaginalis even in the
presence of lactobacilli. Finally, biofilm formation is asso-
ciated with increased antibiotic resistance and appears to
play a role in treatment failure and recurrence in cases of
BV [37]. The difference in biofilm forming capacity
between these two strains could be related to the differ-
ences between the respectively encoded BAPs. The dif-
ferences in domain distribution within the central repeat
region and, potentially more importantly, the number
and distribution of the Rib domains and repeats in strain
AMD could better promote adherence and/or bacterial
aggregation. Furthermore, our results were suggestive of
a correlation between greater biofilm-forming capacity
and association with BV.
This work clearly demonstrates strain differences
between G. vaginalis isolates that could impact the ability
of this organism to cause disease. The precise role for G.
vaginalis in BV pathogenesis is still unclear, but this study
suggests an explanation for the presence of this organism
in the absence of BV. A limitation of this study is the
restricted number of strains studied. Advances in
sequencing technology and the Human Vaginal Micro-
biome Projects, taking place at Virginia Commonwealth
University and the University of Maryland, will lead to
the analysis of additional strains, which will reveal further
insight into the role of the genetic background of G. vagi-
nalis strains in pathogenesis and to clearly demarcate the
differences between strains that are directly related to the
propensity to cause disease.Harwich et al. BMC Genomics 2010, 11:375
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Conclusions
This study provides evidence to support the hypothesis
that certain biotypes of G. vaginalis are unable or unlikely
to cause disease while other strains are better suited to
elicit disease. The results suggest that the strains that fail
to elicit BV may not be able to adhere to, or form a bio-
film on the vaginal epithelium as avidly as strains that
cause BV. Results from genomic sequence analysis identi-
fied significant differences between a strain associated
with BV and a strain from a healthy subject. The sequenc-
ing data reveals genes that may be involved in virulence
and opens up avenues for further study of the pathogene-
sis of BV.
Methods
Gardnerella strains and growth conditions
Gardnerella vaginalis strains 5-1 and 465 were originally
isolated from two healthy women without BV as diag-
nosed by the Nugent gram stain scoring system and
strains 101 and 551 were isolated from women diagnosed
with BV at Brigham and Women's Hospital, Boston, MA
[38]. Strain AMD was isolated from a woman diagnosed
with BV based on Amsel criteria at VCU Women's Health
Clinic [39]. The strains were grown in Brain Heart Infu-
sion (BHI) broth (EMD, Gibbstown, NJ) at 37°C using the
AnaeroPack system (Mitsubishi Gas Chemical Co, Tokyo,
Japan).
DNA isolation
G. vaginalis strains were grown in 200 mL BHI overnight.
The cells were collected by centrifugation, resuspended
in 7 mL TNE buffer (10 mM Tris HCl pH 8.0, 10 mM
NaCl, 10 mM EDTA) containing 1% Triton X-100, and 10
mg lysozyme/mL, and incubated at 37°C for 30 minutes.
Proteinase K (0.3 mg/mL) was added and the suspension
was incubated for 1 hour at 65°C. DNA was extracted
with 7 mL 1:1 phenol/chloroform, followed by 7 mL chlo-
roform, and precipitated with 1/10 volume 3 M sodium
acetate and 2 volumes ethanol.
Sequencing
Sequencing was performed using Roche 454 technology.
One full run of GS FLX and one half run GS FLX XLR
were done for strain 5-1 (coverage of ~175 X), while one
half run of GS FLX XLR was done for strain AMD (~130
× coverage). Five micrograms of each strain's DNA was
sequenced as per the standard Roche sequencing proto-
col.
Sequence analysis
Genomes were assembled by Roche's software Newbler
2.0.00.20 using default parameters. Resulting contigs
were analyzed by Glimmer 3 [40] for gene calling. Trans-
fer RNA genes were predicted using tRNAscan-SE 1.23
[41] and ribosomal RNA genes were found by similarity
searches. Sequences were initially annotated by compari-
son with currently annotated bacterial sequences present
in NCBI's NR protein database. Metabolic reconstruction
and Gene Ontology classification assignments were per-
formed using ASGARD [42], using the UniRef100 data-
base [43]. Other annotation features were predicted using
several programs, namely: transmembrane domain, by
TMHMM 2.0c [44]; signal peptide, by SignalP 3.0b [45];
protein secretion probability, by SecretomeP 2.0 [46];
COG similarities and Pfam domain composition, by rps-
blast [47]; protein characteristics (isoelectric point,
molecular weight, and charge) by pepstat [48]. The
resulting annotation and sequence assemblies were
uploaded to GBrowse [49] installations for visualization
and analysis. Overall DNA sequence identity comparison
of the two strains was performed using MUMmer 3.20
[50]. Determination of putative ortholog relationship
(and therefore the determination of gene uniqueness)
between the genes of the two strains was performed by
OrthoMCL 2.0b6 [51].
Antibiotic resistance assay
G. vaginalis strains 5-1 and AMD were diluted to an
OD600 = 0.1 in BHI supplemented with 1% yeast extract,
2% gelatin, and 0.1% starch (sBHI) containing 1% glucose
(sBHIg). Antibiotics were serially diluted 2-fold in 200 μL
sBHIg in mictotiter wells and 3 μL of the bacterial sus-
pension was added to each well. The microtiter plates
were incubated anaerobically for 24 hours and the lowest
concentrations of antibiotics that prevented visible bacte-
rial growth were recorded.
Electron Microscopy
Bacteria grown overnight in sBHI supplemented with
10% human serum (sBHIs) were collected by centrifuga-
tion, washed in sterile deionized water, spotted onto
formvar-coated 200-mesh copper grids (Electron Micros-
copy Sciences, Hatfield, PA), stained with 2% phospho-
tungstic acid, and analyzed using a Jeol JEM-1230
transmission electron microscope equipped with a Gatan
UltraScan 4000SP 4K x4K CCD camera.
Cytotoxicity
Strains AMD and 5-1 were cultured in sBHIs, collected
by centrifugation, and resuspended in PBS to an OD600 =
0.15. ME-180 monolayers were cultured in 96 well plates
to ~90% confluence, the media was replaced with 100 μL
1× PBS, and 100 μL of the bacterial suspensions was
added. To asses the contact dependence of G. vaginalis-
associated cytotoxicity, ME-180 monolayers were cul-
tured in 6 well plates, the media was replaced with 2 ml of
1× PBS, a sterile transwell with pores of either 0.45 μM or
8 μM was inserted into a well, and 2 ml of the bacterial
suspension was added to the top portion of the transwell.Harwich et al. BMC Genomics 2010, 11:375
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The monolayers were monitored every hour by light
microscopy for cytopathogenic changes, such as cell
rounding, loss of adhesion, and disruption of the mono-
layer. Photos were taken using an Olympus CK2 micro-
scope at magnifications of 100× and 400×.
RNA Isolation and Quantitative RT-PCR
Overnight cultures of the G. vaginalis strains were sub-
cultured 1:20 in 5 ml of sBHIs and grown for ~6 hours
anaerobically at 37°C to mid-exponential phase. The cells
were collected and resuspended in 500 μl of buffer RLT
(Qiagen, Germantown, MD). The suspension was trans-
ferred to Lysing Matrix B tubes (MP Biomedicals, Solon,
OH) and 500 μl of a 5:1 mixture of acid phenol:cholor-
form (Ambion, Austin, TX) was added. The cells were
lysed using a FastPrep FP120 Instrument (Thermo Scien-
tific, Waltham, MA) with settings of power 6 and dura-
tion of 40 seconds. Samples were centrifuged 5 minutes
20,817 rpm at 4°C, the upper layer was transferred to a
new microfuge tube containing 500 μL EtOH (500 μl), the
samples were mixed by inversion, and the RNA purifica-
tion was performed using the RNeasy kit (Qiagen)
according to manufacturer's instructions, and the RNA
was eluted in 90 μl of RNase-free water. DNA was
removed using the Turbo DNA-free kit (Ambion). RNA
was quantified by measurement of absorbance at 260 and
280 nm. Synthesis of cDNA from 1 μg RNA was carried
out using the Tetro® cDNA synthesis kit (Bioline, Taun-
ton, MA) and 1 μM Gv16sc-REV:
5'AGGTACACTCACCCGAAAGC3', MH8: 5'GTTAAT-
GGTGCGCGATTTGC 3', and MH6:
5'GTTGTTAAAGAACACATCGAAG3'. Resulting
cDNA was diluted 1:100, and 2 μl of the diluted cDNA
was used as a template for realtime RT-PCR in reactions
that included 0.4 μM of each forward and reverse primer
as well as Sensimix Plus + Fluorescein (Quantace, Nor-
wood, MA) at a final concentration of 1×. Primer sets
were as follows: 16 S - Gv16sc-FWD:
5'CACATTGGGACTGAGATACGG3' and Gv16sc-REV;
vly - MH7: 5'CTTGCGCAGCCAGCAAGG3' and MH8;
bapL  - MH5: 5'GTGTCATTGAGCACACTTGC3' and
MH6. Control reactions lacked reverse transcriptase
enzyme to ensure that DNA contamination was minimal.
Reactions were performed on an IQ5 Multicolor Realtime
PCR Detection System (Bio-Rad, Hercules, CA). Optimal
hybridization temperatures were determined by perform-
ing reactions over a 10°C gradient. Primer efficiencies
were determined by using five, 5-fold dilutions of cDNA
as template and the resulting Ct values were plotted ver-
sus the Log10 of the dilution factor, yielding a straight
line, the slope of which was then used in the following
equation: Efficiency = 10 (1/m) where m = slope. Reac-
tions were incubated for 10 minutes at 95°C then cycled
for 35 rounds of 10 seconds at 95°C, 10 seconds at the
determined hybridization temperature, and then 15 sec-
onds at 72°C during which data, SYBR green fluores-
cence, was collected. Data following RT-PCR was
corrected for primer efficiency by applying the formula:
Corrected = EfficiencyCt. The corrected value obtained
was normalized to 16 s rRNA expression. Averages were
obtained from technical replicates and standard deviation
was determined. Biological triplicates were performed for
each sample.
Adherence
Bacteria were grown in sBHIs, and ~108 were collected by
centrifugation and resuspended in 1× PBS. ME-180 cervi-
cal epithelial cells (ATCC) were cultured at 37°C in 5%
CO2 in McCoy's 5A medium (Quality Biologic, Gaithers-
burg, MD) supplemented with 10% fetal bovine serum
and 1IU ml-1  penicillin/streptomycin (MediaTech,
Manassass, VA) in 6-well polystyrene plates (Greiner,
Monroe, NC) to 90% confluence. ME-180 cells were
stained with 2.5 μM Vybrant red membrane stain in PBS
and bacteria were stained with a solution of 0.5 μM
BacLight green (Invitrogen, Carlsbad CA) in PBS at 37°C
for 60 minutes. Following staining, epithelial cells and
bacteria were washed twice in 1× PBS, the bacteria were
added to the monolayer in a final volume of 3 mL PBS,
and the plates were centrifuged to maximize contact
between the bacteria and epithelial cells. The bacteria
were allowed to adhere at 4°C for 15 minutes, the mono-
layer was washed 3 times with 1× PBS, and adherence
was visualized using a Zeiss LSM 510 META NLO multi-
photon laser scanning microscope with an Achroplan
63× water dipping objective. BacLight green was excited
with a 488 nm argon laser, Vybrant Red with a 633 nM
laser and emissions filters 515 nm (green) and 630 nm
(red) were used.
Biofilm formation
Strains 5-1 and AMD were grown in sBHIs in 96 well tis-
sue culture-treated plates (Greiner) anaerobically at 37°C
for 24 hours. For a qualitative assessment of biofilm for-
mation, non-adherent bacteria were removed from the
wells and adherent bacteria were stained with safranin.
For a quantitative measure of biofilm formation, plank-
tonic bacteria were removed from the wells and trans-
ferred to new wells, and the biofilms were resuspended in
fresh media. The OD595 was determined for both plank-
tonic as well as biofilm growth. The percent growth as a
biofilm was calculated as OD595 biofilm/(OD595 biofilm +
OD595 planktonic).
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